RxDoctor Payments Data

Yuriko Garcia

Physician Assistant · Mission, TXNPI 1831681279

Payments from drug & device makers

$2,044in general payments, 2019–2025

Across 90 payments — averaging $22.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$363
  • Boehringer Ingelheim$290
  • Lilly USA, LLC$230
  • GSK$198
  • Merck$177
  • Phathom Pharmaceuticals, Inc.$154
  • plus $631 from 17 others

What the payments were for

  • Food & beverage$2,044100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,044 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$81,079
JardianceEmpagliflozin54$65,819
RybelsusSemaglutide24$43,232
FarxigaDapagliflozin Propanediol33$23,202
LinzessLinaclotide26$19,797
TrulicityDulaglutide12$17,176
EliquisApixaban11$5,740
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,910
Diclofenac Sodium67$2,177
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,080
Gabapentin125$1,573
Telmisartan42$1,511
Albuterol Sulfate HfaAlbuterol Sulfate45$1,115
Fluticasone Propionate80$1,106
Omeprazole85$1,008

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$363$124,31282 claims
Boehringer IngelheimJardiance$290$65,81954 claims
AstraZenecaFarxiga$34$23,20233 claims
AbbVieLinzess$47$19,79726 claims
Lilly USA, LLCTrulicity$230$17,17612 claims
PfizerEliquis$82$5,74011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Mission

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →